4//SEC Filing
Turner Nathaniel S. 4
Accession 0001209191-21-003166
CIK 0001801170other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 9:17 PM ET
Size
6.9 KB
Accession
0001209191-21-003166
Insider Transaction Report
Form 4
Turner Nathaniel S.
Director
Transactions
- Award
Class B Common Stock
2021-01-07+2,565,954→ 2,565,954 total(indirect: By LLC)→ Class A Common Stock (2,565,954 underlying)
Footnotes (3)
- [F1]The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation.
- [F2]Received in connection with the Issuer's business combination (the "Business Combination") with Clover Health Investments, Corp. ("Legacy Clover") in accordance with the terms of the Agreement and Plan of Merger dated as of October 5, 2020, among the Issuer (f/k/a Social Capital Hedosophia Holdings Corp. III), Asclepius Merger Sub Inc., and Legacy Clover, as amended by that certain Amendment to the Agreement and Plan of Merger, dated as of December 8, 2020, in exchange for 1,330,273 shares of common stock of Legacy Clover.
- [F3]The Reporting Person is a partner in Multiple Holdings, LLC and may be deemed to share voting power and dispositive power over the shares held by Multiple Holdings, LLC.
Documents
Issuer
CLOVER HEALTH INVESTMENTS, CORP. /DE
CIK 0001801170
Entity typeother
Related Parties
1- filerCIK 0001838734
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 9:17 PM ET
- Size
- 6.9 KB